Vaccines

mr-charung-muengchana-director-national-vaccine-institute-ministry-of-public-health-thailand

Thai vaccine institute: Our nation needs robust vaccine alliances...

  • Thailand
  • |
  • Influencers

According to the WHO, Thailand has nearly 520,000 people (aged 5-to-49) living with HIV and AIDS and the country has the highest adult HIV prevalence in South East Asia region. Public health ministry of Thailand has reported that more than... Read more

dsc0336

Asia vaccine strategists call for collaboration


  • Singapore
  • |
  • News
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Asia needs a solution, that goes beyond traditional structure, models and pathways, to meet the essential vaccine supply... Read more

mers-virus-infecting-middle-east

MERS coronavirus kills four more in Saudi


  • Rest of Asia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The Saudi Arabia Health Ministry on Monday confirmed four more deaths from the new SARS-like coronavirus MERS-CoV.... Read more

dr-wu-ke-founder-shanghai-bravobio-china-winner-of-the-biospectrum-asia-pacific-awards-2013-in-the-emerging-company-of-the-year-2013-category

Shanghai BravoBio wins BioSpectrum award for role in China vaccine industry

  • China
  • |
  • Influencers
  • |
  • By Amrita Tejasvi
  • |
  • 0 Comment

Chinese vaccine development companies are raising the bar to meet international standards. However, access to foreign markets remains a... Read more

vgti-scientists-find-out-why-hiv-vaccines-are-not-effective

HIV vaccine dream can now be a reality

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Scientists at Vaccine and Gene Therapy Institute of Florida (VGTI), US, a nonprofit immunological research institute, showed... Read more

flu-drug

New drug to halt flu virus mutation

  • Australia
  • |
  • News
  • |
  • By Nandita Singh
  • |
  • 0 Comment

A better flu drug is on its way. This new class of specific, mechanism-based anti-influenza drug works by preventing the virus from removing... Read more

vaccine-rotavac

Phase III trial of $1 vaccine RotaVac completed

  • India
  • |
  • News
  • |
  • By Manasi Vaidya
  • |
  • 0 Comment

Pune: The phase III trial of RotaVac, India's first indigenously developed rotavirus vaccine, has been completed and the data is presently... Read more

riboxx-china-national-biotec

China National Biotec, Riboxx ink collaboration

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Germany's Riboxx Pharmaceuticals and China National Biotec Group (CNBG) have initiated a research collaboration to evaluate Riboxxim,... Read more

inviragen-initiates-second-stage-of-phase-ii-trials-of-denvax-dengue-vaccine

Inviragen DENVax dengue vaccine shows promise

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Inviragen initiated second stage of an ongoing phase II, randomized, double-blind, placebo-controlled study of DENVax, the company's... Read more

new-zealand-australian-govt-commit-usd2

NZ, Aus govt commit $2.5 mn for rheumatic vaccine

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The decision by New Zealand and Australian Prime Ministers to investigate potential vaccines against rheumatic fever has been... Read more

more-than-280-000-school-boys-will-get-free-gardasil-vaccine-in-australia

Massive cancer vaccination starts in Aus schools

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australian schoolboys have begun receiving the first-of-three vaccinations to protect them against cancers and disease caused... Read more

allied-sales-rise-13-to-3

Allied sales rise 13% to $3.7 mn in H2, 2012

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australia-based Allied Healthcare has marked a stronger sales with revenues up at 13 percent to $3.7 million for six months ending... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X